-+ 0.00%
-+ 0.00%
-+ 0.00%

Alzchem to Expand Creatine Portfolio Via EUR120 Million Investment

MT Newswires·12/04/2025 11:18:14
Listen to the news
11:18 AM EST, 12/04/2025 (MT Newswires) -- Alzchem (ACT.F) approved a 120 million-euro budget for the construction of a new production facility and other upstream infrastructure for creatine products and precursors. The German specialty chemicals company said Thursday the project aims to expand its creatine portfolio, with a focus on health, nutrition, and pharmaceutical applications. Alzchem also anticipates potential additional annual sales in the low, triple-digit, million-euro range as a result of the investment. Commissioning of the facility is expected to start in the second half of 2027.